SARAJEVO (Bosnia and Herzegovina), August 14 (SeeNews) – Bosnian pharmaceuticals maker Bosnalijek [SAJ:BSNLR] said on Wednesday it has signed a long-term cooperation agreement with drug distributor Imperia-Pharma with a gross value of 11.6 million euro ($15.4 million) that will ensure the continued presence of its products on the growing Russian market.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
